H Taper
Impact in
- Nutrition and Dietetics top 2%
- Microbial Metabolites in Food Biotechnology
- Vitamin C and Antioxidants Research
- Food composition and properties
- Hepatology top 5%
- Liver physiology and pathology
Papers in
-
- Vitamin C and Antioxidants Research 7
- Microbial Metabolites in Food Biotechnology 6
- Co-authors
- Marcel Roberfroid (14 shared papers)Rolf Schulte‐Hermann (4 shared papers)Pedro Buc Calderón (11 shared papers)Nathalie M. Delzenne (8 shared papers)Audrey M. Neyrinck (3 shared papers)Marina Lasa (2 shared papers)Catherine Daubioul (2 shared papers)Wilfried Bursch (3 shared papers)
In The Last Decade
H Taper
52 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 106
- Nutrition and Dietetics 493
- Hepatology 142
- Pharmacology 153
- Toxicology 45
- Cancer Research 176
Countries citing papers authored by H Taper
This map shows the geographic impact of H Taper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Taper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Taper more than expected).
Fields of papers citing papers by H Taper
This network shows the impact of papers produced by H Taper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Taper. The network helps show where H Taper may publish in the future.
Co-authors
The 25 scholars most cited alongside H Taper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 149 | |
| 2 | 2002 | 145 | |
| 3 | 1986 | 133 | |
| 4 | 1997 | 129 | |
| 5 | 1992 | 97 | |
| 6 | Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. | 1991 | 86 |
| 7 | 2009 | 63 | |
| 8 | 2002 | 57 | |
| 9 | 1983 | 55 | |
| 10 | Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. II. Synergism with combined chemotherapy action. | 1993 | 55 |
| 11 | 2002 | 54 | |
| 12 | 1989 | 42 | |
| 13 | 1981 | 38 | |
| 14 | 2008 | 36 | |
| 15 | Inhibition effect of dietary inulin and oligofructose on the growth of transplantable mouse tumor. | 1999 | 34 |
| 16 | 2001 | 34 | |
| 17 | 1988 | 31 | |
| 18 | 1999 | 29 | |
| 19 | 2008 | 26 | |
| 20 | 1988 | 24 |
About H Taper
H Taper is a scholar working on Nutrition and Dietetics, Molecular Biology, Oncology, Epidemiology and Pharmacology, having authored 54 papers that have together received 1.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (9 papers), Vitamin C and Antioxidants Research (7 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), Drug Transport and Resistance Mechanisms (7 papers), Microbial Metabolites in Food Biotechnology (6 papers), Diet, Metabolism, and Disease (5 papers), Liver physiology and pathology (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Nutrition and Dietetics (493 citations), Hepatology (142 citations), Pharmacology (153 citations), Toxicology (45 citations) and Cancer Research (176 citations). H Taper has collaborated with scholars based in Belgium, Germany and Austria. Frequent co-authors include Marcel Roberfroid, Rolf Schulte‐Hermann, Pedro Buc Calderón, Nathalie M. Delzenne, Audrey M. Neyrinck, Marina Lasa, Catherine Daubioul, Wilfried Bursch, M. Lans and Julien Verrax. Their work appears in journals such as Carcinogenesis, Journal of Cancer Research and Clinical Oncology, British Journal Of Nutrition, Life Sciences and Current Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.